SCHEMBL7930730

SCHEMBL7930730

I/C=C/c1ccccc1-c1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.47
ALDH1A1 P00352 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP11B1 P15538 1/20 0.44
PTGS2 P35354 1/20 0.43
KCNA5 P22460 1/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MKNK1 Q9BUB5 2/20 0.41
MKNK2 Q9HBH9 2/20 0.41
ADRA2C P18825 1/20 0.41
TDO2 P48775 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7930734 1.00 CYP2A6 (0.47) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL4820412 0.83 CYP2A6 (0.47) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL7922679 0.80 NOTUM (0.41) ALDH1A1KCNA5LMNAMAPTTP53
SCHEMBL7922682 0.80 NOTUM (0.41) ALDH1A1KCNA5LMNAMAPTTP53
SCHEMBL6688459 0.80 CDK4 (0.47) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL7935558 0.79 BACE1 (0.46) CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL8175555 0.79 BACE1 (0.46) CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL7935560 0.79 BACE1 (0.46) CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL10960411 0.79 CYP2A6 (0.50) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL894805 0.79 ERN1 (0.57) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0879814-B1 Triaromatic compounds, compositions containing them and uses thereof CT INTERNAT DE BR RECH S DERMA (FR) 2001-11-28 EP disclosed
US-6150413-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, BONE AND OPHTHALMOLOGICAL DISORDERS, AS WELL AS MAMMALIAN SKIN AND HAIR CONDITIONS; 4-(4-(BIPHENYL-2-YL)BUT-3-EN-1-YNYL)BENZOIC ACID, FOR EXAMPLE CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-11-21 US disclosed
EP-0879814-A1 Triaromatic compounds, compositions containing them and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1998-11-25 EP disclosed